Treatment of High-Risk Early Stage Lung Cancer - 7 Angebote vergleichen
| Preise | 2014 | 2015 | 2016 | 2019 |
|---|---|---|---|---|
| Schnitt | € 79,78 | € 90,90 | € 91,34 | € 115,33 |
| Nachfrage |
1
Treatment of High-Risk Early Stage Lung Cancer
DE HC NWISBN: 9783319085388 bzw. 3319085387, in Deutsch, Springer International Publishing, gebundenes Buch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd, zzgl. Versandkosten.
Treatment-of-High-Risk-Early-Stage-Lung-Cancer~~Jeffrey-Bogart, Treatment of High-Risk Early Stage Lung Cancer, Hardcover.
Treatment-of-High-Risk-Early-Stage-Lung-Cancer~~Jeffrey-Bogart, Treatment of High-Risk Early Stage Lung Cancer, Hardcover.
2
Symbolbild
Treatment of High-risk Early Stage Lung Cancer
DE HC NWISBN: 9783319085388 bzw. 3319085387, in Deutsch, SPRINGER, gebundenes Buch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, Nicht lagernd, zzgl. Versandkosten.
Treatment of High-risk Early Stage Lung Cancer, 9783319085388, Book, Textbook, No Synopsis Available.
Treatment of High-risk Early Stage Lung Cancer, 9783319085388, Book, Textbook, No Synopsis Available.
3
Treatment of High-Risk Early Stage Lung Cancer
DE HC NWISBN: 9783319085388 bzw. 3319085387, in Deutsch, Springer-Verlag Gmbh, gebundenes Buch, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Treatment of High-Risk Early Stage Lung Cancer: Following very significant advances, it is now widely recognized that definitive treatment should be considered in patients with stage I non-small cell lung cancer (NSCLC) who have pulmonary dysfunction and/or other co-morbidities. This book is a detailed guide to the evaluation and management of these high-risk patients. It first addresses issues such as pathologic considerations, assessment of co-morbidity and the imaging and staging of NSCLC. Surgical and radiotherapy treatment options, including sublobar resection, minimally invasive surgery, brachytherapy, stereotactic body radiotherapy and proton and charged particle therapy, are then discussed in detail. The role of radiofrequency ablation, salvage local therapy and systemic chemotherapy is also considered. Treatment of High-Risk Early Stage Lung Cancer will be of great interest to radiation and medical oncologists, thoracic surgeons, interventional radiologists and pulmonologists. Englisch, Buch.
Treatment of High-Risk Early Stage Lung Cancer: Following very significant advances, it is now widely recognized that definitive treatment should be considered in patients with stage I non-small cell lung cancer (NSCLC) who have pulmonary dysfunction and/or other co-morbidities. This book is a detailed guide to the evaluation and management of these high-risk patients. It first addresses issues such as pathologic considerations, assessment of co-morbidity and the imaging and staging of NSCLC. Surgical and radiotherapy treatment options, including sublobar resection, minimally invasive surgery, brachytherapy, stereotactic body radiotherapy and proton and charged particle therapy, are then discussed in detail. The role of radiofrequency ablation, salvage local therapy and systemic chemotherapy is also considered. Treatment of High-Risk Early Stage Lung Cancer will be of great interest to radiation and medical oncologists, thoracic surgeons, interventional radiologists and pulmonologists. Englisch, Buch.
4
Symbolbild
Treatment of High-Risk Early Stage Lung Cancer
EN HC NW FEISBN: 9783319085388 bzw. 3319085387, in Englisch, 250 Seiten, Springer, gebundenes Buch, neu, Erstausgabe.
Lieferung aus: Vereinigte Staaten von Amerika, Not yet published.
Von Händler/Antiquariat, Amazon.com.
Following very significant advances, it is now widely recognized that definitive treatment should be considered in patients with stage I non-small cell lung cancer (NSCLC) who have pulmonary dysfunction and/or other co-morbidities. This book is a detailed guide to the evaluation and management of these high-risk patients. It first addresses issues such as pathologic considerations, assessment of co-morbidity and the imaging and staging of NSCLC. Surgical and radiotherapy treatment options, including sublobar resection, minimally invasive surgery, brachytherapy, stereotactic body radiotherapy and proton and charged particle therapy, are then discussed in detail. The role of radiofrequency ablation, salvage local therapy and systemic chemotherapy is also considered. Treatment of High-Risk Early Stage Lung Cancer will be of great interest to radiation and medical oncologists, thoracic surgeons, interventional radiologists and pulmonologists., Hardcover, Ausgabe: 1st ed. 2016, Label: Springer, Springer, Produktgruppe: Book, Publiziert: 2017-01-06, Studio: Springer, Verkaufsrang: 6647303.
Von Händler/Antiquariat, Amazon.com.
Following very significant advances, it is now widely recognized that definitive treatment should be considered in patients with stage I non-small cell lung cancer (NSCLC) who have pulmonary dysfunction and/or other co-morbidities. This book is a detailed guide to the evaluation and management of these high-risk patients. It first addresses issues such as pathologic considerations, assessment of co-morbidity and the imaging and staging of NSCLC. Surgical and radiotherapy treatment options, including sublobar resection, minimally invasive surgery, brachytherapy, stereotactic body radiotherapy and proton and charged particle therapy, are then discussed in detail. The role of radiofrequency ablation, salvage local therapy and systemic chemotherapy is also considered. Treatment of High-Risk Early Stage Lung Cancer will be of great interest to radiation and medical oncologists, thoracic surgeons, interventional radiologists and pulmonologists., Hardcover, Ausgabe: 1st ed. 2016, Label: Springer, Springer, Produktgruppe: Book, Publiziert: 2017-01-06, Studio: Springer, Verkaufsrang: 6647303.
5
Treatment of High-Risk Early Stage Lung Cancer
EN NWISBN: 9783319085388 bzw. 3319085387, in Englisch, Springer International Publishing, Springer International Publishing, Springer International Publishing, neu.
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten, Free Shipping on eligible orders over $25, in-stock.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
6
Treatment of High-Risk Early Stage Lung Cancer
EN NWISBN: 9783319085388 bzw. 3319085387, in Englisch, Springer International Publishing, Springer International Publishing, Springer International Publishing, neu.
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten, Free Shipping on eligible orders over $25.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
7
Symbolbild
Treatment of High-Risk Early Stage Lung Cancer (2019)
EN HC NW FEISBN: 9783319085388 bzw. 3319085387, in Englisch, 250 Seiten, Springer, gebundenes Buch, neu, Erstausgabe.
Lieferung aus: Deutschland, Versandfertig in 1 - 2 Werktagen, Versandkostenfrei. Tatsächliche Versandkosten können abweichen.
Von Händler/Antiquariat, DMI Media Europe.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Von Händler/Antiquariat, DMI Media Europe.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…